• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.69% Nasdaq Down1.07%

    Allergan plc (AGN)

    -NYSE
    303.74 Down 4.27(1.39%) Aug 31, 4:02PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 13,062,300   8,677,600   5,914,900  
    Cost of Revenue6,303,800  4,690,700  3,394,300  
    Gross Profit 6,758,500   3,986,900   2,520,600  
    Operating Expenses
    Research Development1,085,900  616,900  402,500  
    Selling General and Administrative3,593,200  2,047,800  1,171,800  
    Non Recurring632,400  695,100  101,000  
    Others2,597,500  842,700  481,100  
    Total Operating Expenses7,909,000  4,202,500  2,156,400  
    Operating Income or Loss (1,267,700) (423,200) 315,700  
    Income from Continuing Operations
    Total Other Income/Expenses Net(149,800)(183,000)(7,500)
    Earnings Before Interest And Taxes(1,300,300)(398,600)356,700  
    Interest Expense411,800  239,800  111,600  
    Income Before Tax(1,712,100)(638,400)245,100  
    Income Tax Expense(81,900)112,700  146,800  
    Minority Interest(300)700  (1,000)
    Net Income From Continuing Ops(1,630,500)(750,400)97,300  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (1,630,500) (750,400) 97,300  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (1,630,500) (750,400) 97,300  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.